TY - JOUR
T1 - Evaluating material-driven regeneration in a tissue engineered human in vitro bone defect model
AU - de Wildt, Bregje W M
AU - Cramer, Esther E A
AU - de Silva, Leanne S
AU - Ito, Keita
AU - Gawlitta, Debby
AU - Hofmann, Sandra
N1 - Funding Information:
This work is part of the research program TTW with project number TTW 016.Vidi.188.021, which is (partly) financed by the Netherlands Organization for Scientific Research (NWO). This research was also financially supported by the Gravitation Program “Materials Driven Regeneration”, funded by the Netherlands Organization for Scientific Research (024.003.013).
Funding Information:
We thank Dewy van der Valk for the transport of the cartilage spheres from Utrecht to Eindhoven. We thank the Multiplex Core Facility of the Laboratory for Translational Immunology of the University Medical Center Utrecht, the Netherlands, for the Luminex analysis.
Publisher Copyright:
© 2022 The Authors
PY - 2023/1
Y1 - 2023/1
N2 - Advanced in vitro human bone defect models can contribute to the evaluation of materials for in situ bone regeneration, addressing both translational and ethical concerns regarding animal models. In this study, we attempted to develop such a model to study material-driven regeneration, using a tissue engineering approach. By co-culturing human umbilical vein endothelial cells (HUVECs) with human bone marrow-derived mesenchymal stromal cells (hBMSCs) on silk fibroin scaffolds with in vitro critically sized defects, the growth of vascular-like networks and three-dimensional bone-like tissue was facilitated. After a model build-up phase of 28 days, materials were artificially implanted and HUVEC and hBMSC migration, cell-material interactions, and osteoinduction were evaluated 14 days after implantation. The materials physiologically relevant for bone regeneration included a platelet gel as blood clot mimic, cartilage spheres as soft callus mimics, and a fibrin gel as control. Although the in vitro model was limited in the evaluation of immune responses, hallmarks of physiological bone regeneration were observed in vitro. These included the endothelial cell chemotaxis induced by the blood clot mimic and the mineralization of the soft callus mimic. Therefore, the present in vitro model could contribute to an improved pre-clinical evaluation of biomaterials while reducing the need for animal experiments.
AB - Advanced in vitro human bone defect models can contribute to the evaluation of materials for in situ bone regeneration, addressing both translational and ethical concerns regarding animal models. In this study, we attempted to develop such a model to study material-driven regeneration, using a tissue engineering approach. By co-culturing human umbilical vein endothelial cells (HUVECs) with human bone marrow-derived mesenchymal stromal cells (hBMSCs) on silk fibroin scaffolds with in vitro critically sized defects, the growth of vascular-like networks and three-dimensional bone-like tissue was facilitated. After a model build-up phase of 28 days, materials were artificially implanted and HUVEC and hBMSC migration, cell-material interactions, and osteoinduction were evaluated 14 days after implantation. The materials physiologically relevant for bone regeneration included a platelet gel as blood clot mimic, cartilage spheres as soft callus mimics, and a fibrin gel as control. Although the in vitro model was limited in the evaluation of immune responses, hallmarks of physiological bone regeneration were observed in vitro. These included the endothelial cell chemotaxis induced by the blood clot mimic and the mineralization of the soft callus mimic. Therefore, the present in vitro model could contribute to an improved pre-clinical evaluation of biomaterials while reducing the need for animal experiments.
KW - 3Rs
KW - Bone regeneration
KW - Co-culture
KW - In situ
KW - In vitro model
KW - Vascularization
UR - http://www.scopus.com/inward/record.url?scp=85140646042&partnerID=8YFLogxK
U2 - 10.1016/j.bone.2022.116597
DO - 10.1016/j.bone.2022.116597
M3 - Article
C2 - 36280106
SN - 8756-3282
VL - 166
SP - 1
EP - 12
JO - Bone
JF - Bone
M1 - 116597
ER -